Affective disorders in acute myocardial infarction and possibilities of their correction with tianeptin


Aim: to study the prevalence, pattern of and trends in affective disorders (AD) in patients with acute myocardial infarction (AMI) and to assess whether they might be corrected with the antidepressant tianeptin.
Subjects and methods. The study enrolled 108 patients with AMI. To detect and evaluate affective spectrum disorders, all the enrolled patients were interviewed on days 2-3 of AMI, by using the screening questionnaire developed at the Moscow Research Institute of Psychiatry (MRIP), Russian Agency for Health Care, and 4-5 days and 2 and 6 months after the onset of AMI they underwent an in-depth psychopathological examination by a psychiatrist who applied the Hamilton Depression Rating Scale (HDRS) and the Hamilton Anxiety Rating Scale (HARS). To correct affective symptomatology in some patients with verified depression, the antidepressant tianeptin was added to the conventional therapy for AMI on its days 5-7.
Results. The screening questionnaire study revealed depressive spectrum disorders in 45.4% of the patients with AMI. The in-depth psychopathological examination confirmed the presence of AD in 40.7%. Mild and moderate depressive episodes were observed in 26.9% of the patients and adjustment disorders were seen in 13.8%. The sensitivity and specificity of the MRIP screening questionnaire for the diagnosis of depressive spectrum disorders in patients with AIM was 86.2 and 69.6%, respectively. The concomitant symptoms of anxiety were detected in 27.8% of the patients with AMI. The duration of a course of antidepressant therapy with tianeptin averaged 3.9±1.1 months. Six moths after AMI, the tianeptin group a showed significant reduction in HDRS scores by 50% (p = 0.0013) and in HARS scores by 52.7% (p = 0.0004) versus the baseline values. During a follow-up, there was no significant decrease in HDRS and HARS scores in a group of patients who refused antidepressant therapy.
Conclusion. Affective spectrum disorders are most common in myocardial infarction (MI). The use of the MRIP screening questionnaire favors a more adequate diagnosis of depressive spectrum disorders in patients with AMI. Tianeptin therapy for AD concurrent with MI causes an evident reduction in psychopathological symptomatology and a statistically significant decrease in HDRS and HARS scores.

About the authors

Yuriy Aleksandrovich Vasyuk


Aleksandr Vyacheslavovich Lebedev


Tat'yana Viktorovna Dovzhenko

Mariya Vladimirovna Semiglazova

Yu A Vasyuk

A V Lebedev

T V Dovzhenko

M V Semiglazova


  1. Antman E. M., Hand M., Armstrong P. W. et al. 2007 focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction. J. Am. Coll. Cardiol. 2008; 51: 210-247.
  2. Benninghoven D., Kaduk A., Wiegand U. et al. Influence of anxiety on the course of heart disease after acute myocardial infarction - risk factor or protective function? Psychother. and Psychosom. 2006; 75: 56-61.
  3. Bush D. E., Ziegelstein R. C., Patel U. V. et al. Post-myocardial infarction depression. Evidence report / Technology assessment No. 123. (Prepared by the Johns Hopkins University Evidence-based Practice Center under contract No. 290-02-0018.) AHRQ publication No. 05-E018-2. Rockville, MD: Agency for Healthcare Research and Quality; 2005.
  4. Parakh K., Thombs B. D., Fauerbach J. A. et al. Effect of depression on late (8 years) mortality after myocardial infarction. Am. J. Cardiol. 2008; 101 (5): 602-606.
  5. Погосова Г. В., Жидко Н. И., Михеева Т. Г., Байчоров И. Х. Клиническая эффективность и безопасность циталопрама у больных с депрессией после перенесенного инфаркта миокарда. Кардиология 2003; 1: 24-29.
  6. Glassman A. H., O'Connor Ch. M., Califf R. M. et al. Sertraline treatment of major depression in patients with acute MI or unstable angina. J. A. M. A. 2002; 288: 701-709.
  7. The ENRICHD Investigators. Effects of treating depression and low perceived social support on clinical events after a myocardial infarction: the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) randomized trial. J. A. M. A. 2003; 289 (23): 3106-3116.
  8. Glassman A. Depression and cardiovascular disease. Pharmacopsychiatry 2008; 41 (6): 221-225.
  9. Luutonen S., Holm H., Salminen J. K. et al. Inadequate treatment of depression after myocardial infarction. Acta Psychiatr. Scand. 2002; 106: 434-439.
  10. Стаценко М. Е., Рыбак В. А., Говоруха О. А. Коррекция тревожно-депрессивных расстройств тианептином у больных с сердечной недостаточностью в раннем постинфарктном периоде. Кардиология 2005; 12: 40-52.
  11. Watkins L. L., Blumenthal J. A., Davidson J. R. et al. Antidepressant use in coronary heart disease patients: impact on survival. Jn: American Psychosomatic Society. 64th annual meeting, Denver, Colorado. - March 1-4, 2006: Abstracts. P. A-95. Abstract 1553. AbstractsForJournal06.pdf
  12. Краснов В. Н. Организационная модель помощи лицам, страдающим депрессиями в условиях территориальной поликлиники: Метод. рекомендации. М.: Медпрактика; 2000.
  13. Hamilton M. The assessment of anxiety states by rating. Br. J. Med. Psychol. 1959; 32: 50-52.
  14. Hamilton M. A rating scale for depression. J. Neurol. Neurosurg. Psychiatry 1960; 23: 56-62.
  15. Juvent M., Douchamps J., Delcourt E. et al. Lack of cardiovascular side effects of the new tricyclic antidepressant tianeptine. A double-blind, placebo-controlled study in young healthy volunteers. Clin. Neuropharmacol. 1990; 13 (1): 48.
  16. Качковский М. А., Крюков Н. Н. Лечение депрессии у больных инфарктом миокарда тианептином. Кардиология 2006; 5: 21-26.
  17. Сыромятникова Л. И., Шестаков В. В., Зубарев М. А. Особенности депрессивных нарушений у больных с ОИМ. В кн.: Материалы Симпозиума "Психовегетативные синдромы у терапевтических больных" XII Российского нац. конгресса "Человек и лекарство". М.; 2005. 18-22.
  18. Чазов Е. И., Оганов Р. Г., Погосова Г. В. и др. Клинико-эпидемиОлогическая прОграмма изучения депРессии в карДиологической практИке у больНых Артериальной гиперТонией и ишемической болезнью сердцА (КООРДИНАТА): первые результаты многоцентрового исследования. Кардиология 2005; 11: 4-10.
  19. Strik J. J., Honig A., Maes M. Depression and myocardial infarction: relationship between heart and mind. Progr. Neuropsychopharmacol. Biol. Psychiatry 2001; 25: 879-892.
  20. Huffman J. C., Smith F. A., Blais M. A. et al. Recognition and treatment of depression and anxiety in patients with acute myocardial infarction. Am. J. Cardiol. 2006; 98: 319-324.
  21. Amin A. A., Jones A. M. H., Nugent K. et al. The prevalence of unrecognized depression in patients with acute coronary syndrome. Am. Heart J. 2006; 152: 928-934.
  22. Ibrahimagic O. C., Sinanovic O., Smajlovic D. Anxiety in acute phase of ischemic stroke and myocardial infarction. Med. Arh. 2005; 59 (6): 366-369.
  23. Strik J. J. M. H., Denollet J., Lousberg R., Honig A. Comparing symptoms of depression and anxiety as predictors of cardiac events and increased health care consumption after myocardial infarction. J. Am. Coll. Cardiol. 2003; 42: 1801-1877.
  24. Корнетов Н. А., Лебедева Е. В. Депрессивные расстройства у пациентов, перенесших инфаркт миокарда. Психиатр. и психофармакотер. 2003; 5 (5): 195-198.
  25. Погосова Г. В., Ромасенко Л. В. Диагностика и терапия депрессии у больных с сердечно-сосудистыми заболеваниями (результаты многоцентрового проспективного исследования КООРДИНАТА). Психиатр. и психофармакотер. 2006; 8 (1): 47-50.
  26. Погосова Г. В., Жидко Н. И., Красницкий В. Б. и др. Клиническая эффективность тианептина у больных ишемической болезнью сердца с коморбидной депрессией. Кардиология 2004; 3: 20-24.



Abstract - 60



  • There are currently no refbacks.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

Address of the Editorial Office:

  • Novij Zykovskij proezd, 3, 40, Moscow, 125167

Correspondence address:

  • Novoslobodskaya str 31c4., Moscow, 127005, Russian Federation

Managing Editor:


© 2018 "Consilium Medicum" Publishing house

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies